Table 2. Emax and Log EC50 Values of WIN55,212-2 and THC-stimulated [35S]GTPγS Binding in Mouse Cortico-hippocampal Membranes.
EC50 | Emax | |
---|---|---|
−log, M | % of stimulation | |
Vehicle | ||
WIN | −6.005±0.09 | 321±11 |
WIN+CPA | −5.654±0.16 | 254±13a |
THC | −7.389±0.37 | 167±11 |
Chronic caffeine | ||
WIN | −6.006±0.08 | 269±8a |
WIN+CPA | −6.035±0.10 | 252±8a |
THC | −7.660±0.56 | 135±8a |
Note that the Emax, but not the EC50, of WIN55,212-2 (WIN) and THC-stimulated [35S]GTPγS binding was significantly decreased in the chronic caffeine group (3 mg/kg/day, for 22 days), compared with control (vehicle-treated) mice. The A1 receptor agonist, CPA (100 nM), reduced the Emax of WIN55,212-2 in control mice, but did not further decrease the Emax of WIN55,212-2 in chronic caffeine-treated mice. The EC50 of WIN in either vehicle or chronic caffeine groups was not significantly affected by CPA (p>0.05, extra sum-of-squares F test). Data represent mean values±SEM (n=4–5) obtained from nonlinear regression analyses of the data shown in Figure 8.
p<0.05, versus corresponding control, calculated using the extra sum-of-squares F test.